Home > Insider Trading > Filing (0001179110-21-009576)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1735438	Meiragtx Holdings Plc	MGTX	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1742734	Richard Giroux	450 East 29Th Street 14Th Floor New York NY 10016	Cfo & Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2021-10-19	1,300	$20.07	839,918	No	4	S	Direct
Ordinary Shares	Disposition	2021-10-20	13,744	$20.93	826,174	No	4	S	Direct
Ordinary Shares	Disposition	2021-10-20	6,956	$21.28	819,218	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	5,152	Indirect	By Spouse
Ordinary Shares	25,000	Indirect	By Aigle Healthcare Partners III LLC
Ordinary Shares	60,000	Indirect	By GRAT

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2021.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.22, inclusive.
The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.09 to $21.08, inclusive.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.09 to $21.59, inclusive.
On September 22, 2021, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person contributed 60,000 ordinary shares of the issuer owned by Aigle Healthcare Partners III LLC to a grantor retained annuity trust.